BNO bionomics limited
Add to My Watchlist 0.00% ! 1.0¢

why is bnc105 targeted as second line therapy?

  1. PRR
    95 Posts.
    clock Created with Sketch.
    14/04/11
    00:39
    Post #: 8263213
    Hi Iam new to this stock and would like to know why is BNC105 targetting second line therapy and not first line as stated In Southern Cross Equites broker report.
    Thanks in advance.
    BNO Price at posting: 64.6¢ Sentiment: Buy Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
NEWS View the latest ASX market news here
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.